The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Signalling pathways of the TNF superfamily: a double-edged sword
Abstract
Two different tumour-necrosis factors (TNFs), first isolated in 1984, were found to be cytotoxic to tumour cells and to induce tumour regression in mice. Research during the past two decades has shown the existence of a superfamily of TNF proteins consisting of 19 members that signal through 29 receptors. These ligands, while regulating normal functions such as immune responses, haematopoiesis and morphogenesis, have also been implicated in tumorigenesis, transplant rejection, septic shock, viral replication, bone resorption, rheumatoid arthritis and diabetes; so indicating their role as 'double-edged swords'. These cytokines either induce cellular proliferation, survival, differentiation or apoptosis. Blockers of TNF have been approved for human use in treating TNF-linked autoimmune diseases in the United States and other countries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF-α is a pro-inflammatory cytokine and a potent activator of the transcription factor NF-κB, which induces the expression of a multitude of pro-mitogenic, pro-inflammatory, and anti-apoptotic proteins, thus promoting cell proliferation and survival [102].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [102]
In the citing paper
“However, TNF-α is also a powerful apoptotic inducer in vitro when NF-κB signaling is blocked, typically by the addition of cycloheximide.”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [102]
In the citing paper
“Tumor necrosis factor alpha (TNFα) is a pleiotropic cytokine that acts on its receptors (TNFRs) to promote either cell survival or cell death 54.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [54]
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,736
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
Flagged first, then by citations
Research works printed but not linked: 2
- Bruns, P. Die Heilwirkung des Erysipels auf Geschwulste. Beitr. Klin. Chir. 3, 443–446 (1868).
- Gratia, A. & Linz, R. C. R. Seances Soc. Biol. Ses Fil. 108, 421–428 (1931).
Cited by
Sorted by citations
Items 201–300 of 1,004
Takada, Y., Fang, X., Jamaluddin, M. S., Boyd, D. D., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403449200 · Cited by 180
Self-citationYodkeeree, S., Sung, B., Limtrakul, P., & Aggarwal, B. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1161 · Cited by 181
Self-citationErythropoietin, erythropoiesis and beyond
Chateauvieux, S., Grigorakaki, C., Morceau, F., Dicato, M. A., & Diederich, M. F. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.045 · Cited by 180
Chen, R., Alvero, A. B., Silasi, D., & Mor, G. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2006.00441.x · Cited by 182
Shishodia, S., & Aggarwal, B. B. (2005) · Oncogene · doi:10.1038/sj.onc.1209194 · Cited by 179
Self-citationSystemic use of tumor necrosis factor alpha as an anticancer agent
Roberts, N. J., Zhou, S., Diaz, L. A., & Holdhoff, M. (2011) · Oncotarget · doi:10.18632/oncotarget.344 · Cited by 178
Role of inflammation in the progression of heart failure
Yndestad, A., Damås, J. K., Øie, E., Ueland, T., Gullestad, L. L., & Aukrust, P. (2007) · Current Cardiology Reports · doi:10.1007/bf02938356 · Cited by 177
van de Ven, K., & Borst, J. G. (2015) · Immunotherapy · doi:10.2217/imt.15.32 · Cited by 184
Molecular docking for virtual screening of natural product databases
Ma, D., Chan, D. S., & Leung, C. (2011) · Chemical Science · doi:10.1039/c1sc00152c · Cited by 182
Tumor necrosis factor induces GSK3 kinase–mediated cross-tolerance to endotoxin in macrophages
Park, S. H., Park‐Min, K., Chen, J., Hu, X., & Ivashkiv, L. B. (2011) · Nature Immunology · doi:10.1038/ni.2043 · Cited by 183
Schmidt-Ullrich, R., Tobin, D. J., Lenhard, D., Schneider, P., Paus, R., & Scheidereit, C. (2006) · Development · doi:10.1242/dev.02278 · Cited by 171
Liang, D., Li, F., Fu, Y., Cao, Y., Song, X., Wang, T., Wang, W., Guo, M., Zhou, E., Li, D., et al. (2013) · Inflammation · doi:10.1007/s10753-013-9732-x · Cited by 173
Kruyt, F. A. E. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.003 · Cited by 172
Ferulic acid protects against carbon tetrachloride-induced liver injury in mice
Kim, H.-Y., Park, J., Lee, K.-H., Lee, D., Kwak, J.-H., Kim, Y. S., & Lee, S. (2011) · Toxicology · doi:10.1016/j.tox.2011.01.017 · Cited by 171
ADAM17 as a Therapeutic Target in Multiple Diseases
Arribas, J., & Esselens, C. W. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682398 · Cited by 171
Parsons, M. J., & Green, D. R. (2010) · Essays in Biochemistry · doi:10.1042/bse0470099 · Cited by 178
Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration
Dong, Y., Fischer, R., Naudé, P. J. W., Maier, O., Nyakas, C. J., Duffey, M., van der Zee, E. A., Dekens, D. W., Douwenga, W., Herrmann, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605195113 · Cited by 169
Hypothalamic innate immune reaction in obesity
Kälin, S., Heppner, F. L., Bechmann, I., Prinz, M., Tschöp, M. H., & Yi, C.-X. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.48 · Cited by 167
Sabbagh, L., Pulle, G., Liu, Y., Tsitsikov, E. N., & Watts, T. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8093 · Cited by 167
A Metal‐Based Inhibitor of Tumor Necrosis Factor‐α
Leung, C., Zhong, H., Yang, H., Cheng, Z., Chan, D. S., Ma, V. P., Abagyan, R. A., Wong, C., & Ma, D. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202937 · Cited by 165
Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation
Schreiber, T. H., Wolf, D., Tsai, M. S., Chirinos, J., Deyev, V. V., Gonzalez, L. E., Malek, T. R., Levy, R. B., & Podack, E. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42933 · Cited by 163
Suo, Y., Li, E., Li, T., Jia, Y., Qin, J. G., Gu, Z., & Chen, L. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.02.008 · Cited by 163
Obesity, Neuroinflammation, and Reproductive Function
Lainez, N. M., & Coss, D. (2019) · Endocrinology · doi:10.1210/en.2019-00487 · Cited by 180
Kashiwakura, J., Yokoi, H., Saito, H., & Okayama, Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5247 · Cited by 165
Kandhaya-Pillai, R., Miro-Mur, F., Alijotas-Reig, J., Tchkonia, T., Kirkland, J. L., & Schwartz, S. (2017) · Aging · doi:10.18632/aging.101328 · Cited by 165
Bioactive sphingolipids in the modulation of the inflammatory response
El‐Alwani, M., Wu, B. X., Obeid, L. M., & Hannun, Y. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.004 · Cited by 168
The advent of the cytokine storm
Clark, I. A. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100062 · Cited by 160
Hu, S., Liang, S., Guo, H., Zhang, D., Li, H., Wang, X., Yang, W., Qian, W., Hou, S., Wang, H., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.491530 · Cited by 161
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy
Bouchlaka, M. N., Sckisel, G. D., Chen, M., Mirsoian, A., Zamora, A. E., Maverakis, E., Wilkins, D. E. C., Alderson, K. L., Hsiao, H., Weiss, J. M., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20131219 · Cited by 162
Tumor-Elicited Inflammation and Colorectal Cancer
Wang, K., & Karin, M. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.014 · Cited by 167
Recent Advances in Anti-cancer Protein/Peptide Delivery
Liu, X., Wu, F., Ji, Y. I., & Yin, L. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00750 · Cited by 163
TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine
Faustman, D. L., & Davis, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00478 · Cited by 160
Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells
Campbell, S., Burkly, L. C., Gao, H.-X., Berman, J. W., Su, L., Browning, B., Zheng, T. S., Schiffer, L. E., Michaelson, J. S., & Putterman, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1889 · Cited by 157
Huang, N.-L., Chiang, S.-H., Hsueh, C., Liang, Y., Chen, Y.-J., & Lai, L. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.04.010 · Cited by 162
Paulsen, M. T., Veloso, A., Prasad, J., Bedi, K., Ljungman, E. A., Tsan, Y.-C., Chang, C., Tarrier, B., Washburn, J. G., Lyons, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219192110 · Cited by 162
An evolutionary perspective on the necroptotic pathway
Dondelinger, Y., Hulpiau, P., Saeys, Y., Bertrand, M. J. M., & Vandenabeele, P. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.06.004 · Cited by 159
Heparanase and the hallmarks of cancer
Jayatilleke, K. M., & Hulett, M. D. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02624-1 · Cited by 167
Dogra, C., Changotra, H., Mohan, S., & Kumar, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511131200 · Cited by 159
Infectious diseases of marine molluscs and host responses as revealed by genomic tools
Guo, X., & Ford, S. E. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0206 · Cited by 158
TRAF ‐Mediated TNFR ‐Family Signaling
Arron, J. R., Walsh, M. C., & Choi, Y. (2002) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109ds51 · Cited by 157
Fine-tuning of dendritic cell biology by the TNF superfamily
deLuca, L. S., & Gommerman, J. L. (2012) · Nature reviews. Immunology · doi:10.1038/nri3193 · Cited by 154
Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines
Kim, E. Y., & Moudgil, K. D. (2017) · Cytokine · doi:10.1016/j.cyto.2017.04.012 · Cited by 157
El-Deeb, N., Yassin, A. M., Al-Madboly, L. A., & El-Hawiet, A. M. (2018) · Microbial Cell Factories · doi:10.1186/s12934-018-0877-z · Cited by 144
Kusnadi, A., Park, S. H., Yuan, R., Pannellini, T., Giannopoulou, E., Oliver, D., Lu, T., Park-Min, K.-H., & Ivashkiv, L. B. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.005 · Cited by 157
Mahrus, S., & Craik, C. S. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.03.006 · Cited by 156
Rapid mitochondrial dysfunction mediates TNF ‐alpha‐induced neurotoxicity
Doll, D. N., Rellick, S. L., Barr, T. L., Ren, X. S., & Simpkins, J. W. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.13008 · Cited by 155
The multifaceted roles of TRAFs in the regulation of B-cell function
Bishop, G. A. (2004) · Nature reviews. Immunology · doi:10.1038/nri1462 · Cited by 155
Zheng, L., Bidère, N., Staudt, D., Cubre, A., Orenstein, J. M., Chan, F. K.-M., & Lenardo, M. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3505-3513.2006 · Cited by 155
Krueger, J. M. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s176 · Cited by 160
Ahn, K. S., Sethi, G., & Aggarwal, B. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028787 · Cited by 154
Self-citationThe TNF–TNFR Family of Co-signal Molecules
So, T., & Ishii, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_3 · Cited by 156
TRAF‐Mediated TNFR‐Family Signaling
Ha, H., Han, D., & Choi, Y. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109ds87 · Cited by 159
TAK1 Is a Master Regulator of Epidermal Homeostasis Involving Skin Inflammation and Apoptosis
Omori, E., Matsumoto, K., Sanjo, H., Sato, S., Akira, S., Smart, R. C., & Ninomiya‐Tsuji, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603384200 · Cited by 154
Role of Redox Status in Development of Glioblastoma
Salazar, A., Ortega, D. R., de la Cruz, V. P., Hernández‐Pedro, N., González‐Esquivel, D. F., Sotelo, J., & Pineda, B. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00156 · Cited by 158
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
Wandrer, F., Liebig, S., Marhenke, S., Vogel, A., John, K., Manns, M. P., Teufel, A., Itzel, T., Longerich, T., Maier, O., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2411-6 · Cited by 156
Robles, J. P., Zamora, M., Adán‐Castro, E., Siqueiros‐Márquez, L., de la Escalera, G. M., & Clapp, C. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101695 · Cited by 156
Bonavida, B., Baritaki, S., Huerta‐Yépez, S., Vega, M. I., Chatterjee, D., & Yeung, K. C. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.018 · Cited by 152
Bharadwaj, U., Marin-Muller, C., Li, M., Chen, C., & Yao, Q. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-106 · Cited by 151
“TNF-a induces NF- B activation in most cells [17,18] but this is not always sufficient to avoid the pro-apoptotic effects of TNF-a; rather, a constitutive activation of NF- B seems to be necessary [20].”
BackgroundNew perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis
Liu, Y.-W., Liong, M., & Tsai, Y.-C. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-8079-2 · Cited by 158
Signals and ReceptorsPreprint
Heldin, C., Lu, B. C., Evans, R. M., & Gutkind, J. S. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005900 · Cited by 163
Shishodia, S., Sethi, G., Konopleva, M. Y., Andreeff, M., & Aggarwal, B. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2044 · Cited by 147
Self-citationMetformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages
Hyun, B., Shin, S., Lee, A., Lee, S., Song, Y., Ha, N., Cho, K., & Kim, K. (2013) · Immune Network · doi:10.4110/in.2013.13.4.123 · Cited by 151
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
Li, M., Wang, M., Wen, Y., Zhang, H., Zhao, G., & Gao, Q. (2023) · MedComm · doi:10.1002/mco2.349 · Cited by 165
Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD
Reiley, W. W., Zhang, M., & Sun, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411049200 · Cited by 148
Beyond RNAi: Antiviral defense strategies in Drosophila and mosquito
Merkling, S. H., & van Rij, R. P. (2012) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2012.07.004 · Cited by 157
Kajino‐Sakamoto, R., Inagaki, M., Lippert, E., Akira, S., Robine, S., Matsumoto, K., Jobin, C., & Ninomiya‐Tsuji, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1143 · Cited by 147
Ruiz, P. A., & Haller, D. (2006) · Journal of Nutrition · doi:10.1093/jn/136.3.664 · Cited by 147
Ju, W., Wang, X., Shi, H., Chen, W., Belinsky, S. A., & Lin, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032185 · Cited by 146
Mai, C., Yaeghoobi, M., Abd-Rahman, N., Kang, Y. B., & Pichika, M. R. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.002 · Cited by 147
Fujita, Y., Mihara, T., Okazaki, T., Shitanaka, M., Kushino, R., Ikeda, C., Negishi, H., Liu, Z., Richards, J. S., & Shimada, M. (2011) · Human Reproduction · doi:10.1093/humrep/der234 · Cited by 159
Weskamp, G., Mendelson, K., Swendeman, S. L., Gall, S. M. L., Ma, Y., Lyman, S. L., Hinoki, A., Eguchi, S., Guaiquil, V. H., Horiuchi, K., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.207415 · Cited by 147
Schattenberg, J. M., Galle, P. R., & Schuchmann, M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01324.x · Cited by 144
Molecular Mechanisms of Cancer-Induced Sleep Disruption
Walker, W. H., II, & Borniger, J. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112780 · Cited by 149
Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models
Ki Han, K. W. O. N., Barve, A., Yu, S., Huang, M., & Kong, A. T. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00694.x · Cited by 146
Manu, K. A., & Kuttan, G. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.02.013 · Cited by 147
Cytotoxicity of TNFα is regulated by integrin‐mediated matrix signaling
Chen, C., Young, J. L., Monzon, R. I., Chen, N., Todorović, V., & Lau, L. F. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601596 · Cited by 143
Khodarev, N. N., Minn, A. J., Efimova, E. V., Darga, T. E., Labay, E., Beckett, M., Mauceri, H. J., Roizman, B., & Weichselbaum, R. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1019 · Cited by 147
Mechanisms Linking Excess Adiposity and Carcinogenesis Promotion
Pérez-Hernández, A. I., Catalán, V., Gómez‐Ambrosi, J., RodrÃguez, A., & Frühbeck, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00065 · Cited by 148
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis
Reißfelder, C., Stamova, S., Gossmann, C., Braun, M., Bonertz, A., Walliczek, U., Grimm, M., Rahbari, N. N., Koch, M., Saadati, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74894 · Cited by 140
TNFR2: A Novel Target for Cancer Immunotherapy
Vanamee, É. S., & Faustman, D. L. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.09.007 · Cited by 142
Amin, P. P., Florez, M. A., Najafov, A., Pan, H., Geng, J., Ofengeim, D., Dziedzic, S. A., Wang, H., Barrett, V. J., Ito, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806973115 · Cited by 143
A Novel TNF-α-Targeting Aptamer for TNF-α-Mediated Acute Lung Injury and Acute Liver Failure
Lai, W., Wang, J.-W., Huang, B.-T., Lin, E. P.-Y., & Yang, P. (2019) · Theranostics · doi:10.7150/thno.30972 · Cited by 145
A Metal‐Based Inhibitor of Tumor Necrosis Factor‐α
Leung, C., Zhong, H., Yang, H., Cheng, Z., Chan, D. S., Ma, V. P., Abagyan, R. A., Wong, C., & Ma, D. (2012) · Angewandte Chemie · doi:10.1002/ange.201202937 · Cited by 142
A New Class of Reverse Signaling Costimulators Belongs to the TNF Family
Sun, M., & Fink, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4307 · Cited by 141
Role of Epigenetics in Inflammation-Associated diseases
Shanmugam, M. K., & Sethi, G. (2013) · Subcellular Biochemistry · doi:10.1007/978-94-007-4525-4_27 · Cited by 141
Shui, L., Ren, H., Yang, X., Li, J., Chen, Z., Cheng, Y., Zhu, H., & Shui, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.570465 · Cited by 150
Bettini, M., & Ziegler, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5024 · Cited by 146
Bonavida, B., & Garbán, H. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.013 · Cited by 143
Guarini, A. R., Chiaretti, S., Tavolaro, S., Maggio, R., Peragine, N., Citarella, F., Ricciardi, M. R., Santangelo, S., Marinelli, M., Propris, M. S. D., et al. (2008) · Blood · doi:10.1182/blood-2007-12-127688 · Cited by 140
Importance of TNFα and neutral lipases in human adipose tissue lipolysis
Langin, D., & Arner, P. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.003 · Cited by 140
Ubiquitin enzymes in the regulation of immune responses
Ebner, P., Versteeg, G. A., & Ikeda, F. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1325829 · Cited by 143
Rebholz, B., Haase, I., Eckelt, B., Paxian, S. A., Flaig, M. J., Ghoreschi, K., Nedospasov, S. A., Mailhammer, R., Debey‐Pascher, S., Schultze, J. L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.024 · Cited by 138
Steeland, S., Libert, C., & Vandenbroucke, R. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051442 · Cited by 145
Huang, Y., Chen, Y., Zhou, S., Liang, C., Wang, J., Pei, Y., Xu, M., Feng, J., Jiang, T., Liang, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14425-7 · Cited by 137
Distinct Signaling Pathways in TRAIL- versus Tumor Necrosis Factor-Induced Apoptosis
Jin, Z., & El‐Deiry, W. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00257-06 · Cited by 137
Chen, X., Hamano, R., Subleski, J. J., Hurwitz, A. A., Howard, O. M. Z., & Oppenheim, J. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903548 · Cited by 143
Li, C., Yang, Z., Zhai, C., Qiu, W., Li, D., Yi, Z., Wang, L., Tang, J., Qian, M., Luo, J., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-73 · Cited by 136
Georgantas, R. W., Streicher, K. L., Greenberg, S. A., Greenlees, L. M., Zhu, W. P., Brohawn, P. Z., Higgs, B. W., Czapiga, M., Morehouse, C. A., Amato, A. A., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38292 · Cited by 136
Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease
Hsiao, H., Chiu, F., Chen, C., Wu, Y., Chen, H., Chen, Y., Kuo, H., & Chern, Y. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu151 · Cited by 135
The redox biology network in cancer pathophysiology and therapeutics
Manda, G., Isvoranu, G., Comanescu, M. V., Manea, A., BÜTÜNER, B. D., & Korkmaz, K. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.014 · Cited by 139
Metadata
- Authors
- Aggarwal, B. B.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Aggarwal, Bharat B.
- ORCID
- Aggarwal, Bharat B.
- Venue
- Nature Reviews Immunology
- Published
- 2003-09
- Volume
- 3
- Issue
- 9
- Pages
- 745-756
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2095013915
- Cited by
- 2,793
- References
- 124
- Citations by year
- 2026: 74 · 2025: 107 · 2024: 82 · 2023: 121 · 2022: 125 · 2021: 114 · 2020: 132 · 2019: 113 · 2018: 114 · 2017: 130 · 2016: 108 · 2015: 142 · 2014: 128 · 2013: 116 · 2012: 159
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- TNF superfamily, TNF-α, TNF receptor, signaling pathways, carcinogenesis, graft rejection, septic shock, viral replication, bone resorption, rheumatoid arthritis, diabetes mellitus, apoptosis, TNF-alpha inhibitors, autoimmune disease, cytokines
- MeSH terms
- Animals, Autoimmune Diseases, Carrier Proteins, Humans, Ligands, Lymphotoxin-alpha, Membrane Proteins, Tumor Necrosis Factor-alpha, Signal Transduction, NF-kappa B, Receptors, Tumor Necrosis Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review